Ginkor gel (Gel) Instructions for Use
Marketing Authorization Holder
Ipsen Pharma (France)
Manufactured By
Beaufour Ipsen Industrie (France)
ATC Code
C05CA (Bioflavonoids)
Active Substances
Troxerutin (Rec.INN registered by WHO)
Ginkgo biloba (BP British Pharmacopoeia)
Dosage Form
| Ginkor gel | Gel for external use 1.4 mg+30 mg/1 g: tube 40 g |
Dosage Form, Packaging, and Composition
Gel for external use yellow in color, transparent; the presence of air bubbles is allowed.
| 100 g | |
| Dry standardized Ginkgo biloba extract | 140 mg, |
| Including ginkgo flavonol glycosides | 24% |
| Ginkgolides-bilobalides | 6% |
| Troxerutin | 3 g |
Excipients : methylparaben 120 mg, propylparaben 30 mg, disodium edetate 20 mg, carbomer (carboxypolymethylene) 1.2 g, isopropanol 8 g, purified water (up to 100 g).
40 g – aluminum tubes (1) – cardboard packs.
Clinical-Pharmacological Group
Venotonic drug for topical application
Pharmacotherapeutic Group
Venotonic agent of plant origin
Pharmacological Action
A drug used for venous circulation disorders. Increases capillary resistance, reduces their increased permeability, optimizes vascular tone, regulates capillary capacity. Promotes increased glucose consumption, elimination of lactates and other metabolic products, and restoration of aerobic glycolysis in tissues.
It has an anti-edema effect, reduces transudation of plasma proteins and leukocyte infiltration by inhibiting phospholipase A2, lipoxygenase and blocking platelet activating factor.
It has antioxidant properties, blocks free radicals and has a protective effect on lysosomal membranes.
Increases the resistance of venous endothelial cells to hypoxia, inhibits the breakdown of collagen microfibers and normalizes the functions of vascular smooth muscle.
Improves the rheological properties of blood by increasing the resistance of erythrocyte membranes and reducing their aggregation. In case of platelet hyperaggregation, the use of the drug reduces the likelihood of thrombus formation.
Indications
- Functional manifestations of chronic venous insufficiency of the lower extremities with signs of inflammation and trophic skin disorders;
- Bruises and local hematomas, burning sensation and cramps in the lower extremities;
- Painful inflammatory reactions to the administration of injectable drugs for the treatment of varicose veins;
- Superficial phlebitis.
ICD codes
| ICD-10 code | Indication |
| I80.0 | Phlebitis and thrombophlebitis of superficial vessels of lower extremities |
| I87.2 | Venous insufficiency (chronic) (peripheral) |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| ICD-11 code | Indication |
| BD70.0 | Superficial thrombophlebitis of lower extremities |
| BD74.Z | Chronic venous insufficiency of lower extremities, unspecified |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| ND56.0 | Superficial injury of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply the gel to clean, intact skin on the affected area.
Determine the amount used by the size of the skin surface requiring treatment.
Use a quantity approximately equal to the volume of a hazelnut for an area the size of the lower leg’s posterior surface.
Administer the preparation two to four times daily.
Perform a light massage during each application until the gel is fully absorbed.
Continue treatment for the entire duration prescribed by a physician.
Do not apply to mucous membranes, eczematous skin, or open wounds.
Avoid exposing the treated skin areas to direct sunlight after application.
Adverse Reactions
Possible local reactions.
Contraindications
Currently, no contraindications have been established.
Use in Pregnancy and Lactation
Data on the safety and efficacy of the drug during pregnancy and lactation (breastfeeding) have not been provided.
In experimental studies, it was found that the drug does not have a teratogenic effect.
Special Precautions
Ginkor gel should not be applied to mucous membranes, or to areas of skin with eczema or open ulcerations.
Exposure of the treated skin areas to sunlight should be avoided.
Overdose
To date, no cases of Ginkor gel overdose have been reported.
Drug Interactions
No clinically significant interaction of Ginkor gel with other drugs has been established.
Storage Conditions
The drug should be stored at a temperature not exceeding 25°C (77°F).
Pharmacy supply terms
The drug is approved for use as an over-the-counter product.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Noopept, pills 10mg, 50pcs
No-spa pills 40mg, 64pcs
Kagocel pills 12mg, 30pcs
Fenotropil pills 100mg, 60pcs
Picamilon pills 50mg, 60pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Nootropil pills 800mg, 30pcs
Phenibut-Vertex pills 250mg, 20pcs
Mildronate capsules 500mg, 90pcs
Belosalic, ointment, 30g
Belosalic, lotion solution for external use spray 100ml 